GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Icecure Medical Ltd (NAS:ICCM) » Definitions » Total Liabilities

ICCM (Icecure Medical) Total Liabilities : $5.68 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Icecure Medical Total Liabilities?

Icecure Medical's Total Liabilities for the quarter that ended in Dec. 2024 was $5.68 Mil.

Icecure Medical's quarterly Total Liabilities increased from Jun. 2024 ($4.75 Mil) to Sep. 2024 ($5.22 Mil) and increased from Sep. 2024 ($5.22 Mil) to Dec. 2024 ($5.68 Mil).

Icecure Medical's annual Total Liabilities declined from Dec. 2022 ($4.77 Mil) to Dec. 2023 ($4.25 Mil) but then increased from Dec. 2023 ($4.25 Mil) to Dec. 2024 ($5.68 Mil).


Icecure Medical Total Liabilities Historical Data

The historical data trend for Icecure Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icecure Medical Total Liabilities Chart

Icecure Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.59 5.32 4.77 4.25 5.68

Icecure Medical Quarterly Data
Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.25 4.42 4.75 5.22 5.68

Icecure Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Icecure Medical's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.514+(0.161+-4.1633363423443E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=5.68

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=12.576-6.901
=5.68

Icecure Medical's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.514+(0.161+-4.1633363423443E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=5.68

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=12.576-6.901
=5.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Icecure Medical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Icecure Medical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Icecure Medical Business Description

Traded in Other Exchanges
N/A
Address
7 Haeshel Street, Southern Industrial Park, PO Box 3163, Caesarea, ISR, 3079504
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Icecure Medical Headlines

From GuruFocus